IGF-1 LR3 is a modified analog of insulin-like growth factor-1 developed for laboratory research applications. The LR3 modification alters the peptide structure to extend its half-life and reduce its binding affinity to insulin-like growth factor binding proteins (IGFBPs), allowing for prolonged activity in experimental systems.

In research settings, IGF-1 LR3 is commonly studied for its involvement in cellular growth signaling, survival pathways, protein synthesis modeling, and muscle regeneration frameworks. It is frequently utilized in investigations examining myocyte behavior, tissue growth models, metabolic signaling pathways, and mechanisms related to cellular survival and differentiation.

This compound is supplied exclusively for controlled laboratory research and investigational use.

Key Research Areas

• Protein synthesis modeling

• Muscle regeneration and repair pathways

• Cellular differentiation studies

• Recovery and adaptation models

• IGF signaling mechanisms

• Metabolic and energy balance research

Peptide Characteristics

• Form: Lyophilized peptide

• Purity: ≥98%

• Structure: Sequence modified for extended activity

• Functional Profile: Extended half-life compared to native IGF-1

Storage Guidelines

• Store lyophilized material at −20 °C

• Store reconstituted solutions at 2–8 °C

• Avoid repeated freeze–thaw cycles

Reconstitution

Reconstitute using appropriate laboratory-grade solvent under sterile research conditions. Allow the peptide to dissolve gently. Final research concentrations depend on experimental protocol design.

Research Use Disclaimer

• For laboratory research use only

• Not for human consumption

• Not for medical, therapeutic, or diagnostic use

• Not a drug, food, or dietary supplement

• Proper research qualifications required